Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.58 |
| ▸ | PGD | P52209 | 3/20 | 0.48 |
| ▸ | PGK1 | P00558 | 1/20 | 0.42 |
| ▸ | PGK2 | P07205 | 1/20 | 0.42 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | SGPL1 | O95470 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3507132 | 1.00 | MPI (0.58) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL20553435 | 1.00 | MPI (0.58) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL1353551 | 1.00 | MPI (0.58) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL4594608 | 0.88 | MPI (0.62) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL20857032 | 0.88 | MPI (0.62) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL139868 | 0.88 | MPI (0.62) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL2234036 | 0.86 | MPI (0.60) | MPIPGDPGK1PGK2LPAR5 | |
| Cetyl Alcohol SCHEMBL3167243 | 0.84 | LPAR5 (0.46) | MPILPAR5SGPL1 | |
| Acetaldehyde SCHEMBL22264056 | 0.83 | MPI (0.56) | MPIPGDPGK1PGK2LPAR5 | |
| SCHEMBL16416132 | 0.81 | PGD (0.61) | MPIPGDPGK1PGK2LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 880 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| WO-2025134122-A1 | DIAGNOSTIC AGENTS AND USES THEREOF | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) | 2025-06-26 | — | — | WO | claimed |
| WO-2024190663-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| US-11723934-B2 | Compositions and methods for the induction of CD8+ T-cells | KEIO UNIVERSITY (JP) | 2023-08-15 | — | — | US | claimed |
| US-20220023207-A1 | DRUG DELIVERY SYSTEM USING SOLUTION | KYOTO UNIVERSITY (JP) | 2022-01-27 | — | — | US | claimed |
| EP-3888693-A1 | DRUG DELIVERY SYSTEM USING SOLUTION | Kyoto University (JP) | 2021-10-06 | — | — | EP | claimed |
| CN-113195003-A | Drug delivery system using solution | 国立大学法人京都大学 | 2021-07-30 | — | — | CN | claimed |
| US-20170281772-A1 | A NEURAL SUBSTRATE FOR SUGAR PREFERENCE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2017-10-05 | — | — | US | claimed |
| US-8604278-B2 | Expression cassettes for transgenic expression of nucleic acids | SUNGENE GMBH & CO. KGAA (DE) | 2013-12-10 | — | — | US | claimed |
| US-20110289622-A1 | EXPRESSION CASSETTES FOR TRANSGENIC EXPRESSION OF NUCLEIC ACIDS | SUNGENE GMBH & CO. KGAA (DE) | 2011-11-24 | — | — | US | claimed |
| WO-2003008596-A2 | EXPRESSION CASSETTES FOR TRANSGENICALLY EXPRESSING SELECTION MARKERS | SUNGENE GMBH & CO. KGAA (DE) | 2003-01-30 | — | — | WO | claimed |
| WO-2003006660-A1 | EXPRESSION CASSETTES FOR THE TRANSGENIC EXPRESSION OF NUCLEIC ACIDS | SUNGENE GMBH & CO. KGAA (DE) | 2003-01-23 | — | — | WO | claimed |
| US-6472201-B1 | GROWING AND TESTING MICROORGANISMS IN A MULTITEST FORMAT WHICH UTILIZES A GEL FORMING MATRIX FOR THE RAPID SCREENING OF CLINICAL AND ENVIRONMENTAL CULTURES | BIOLOG, INC. | 2002-10-29 | — | — | US | claimed |
| EP-0973921-B1 | 2-DEOXYGLUCOSE-6-PHOSPHATE (2-DOG-6-P) PHOSPHATASE DNA SEQUENCES AS SELECTION MARKERS IN PLANTS | IPK GATERSLEBEN (DE) | 2001-09-05 | — | — | EP | claimed |
| EP-0973921-A1 | 2-DEOXYGLUCOSE-6-PHOSPHATE (2-DOG-6-P) PHOSPHATASE DNA SEQUENCES AS SELECTION MARKERS IN PLANTS | IPK Gatersleben (DE) | 2000-01-26 | — | — | EP | claimed |
| WO-1998045456-A1 | 2-DEOXYGLUCOSE-6-PHOSPHATE (2-DOG-6-P) PHOSPHATASE DNA SEQUENCES AS SELECTION MARKERS IN PLANTS | IPK GATERSLEBEN (DE) | 1998-10-15 | — | — | WO | claimed |
| EP-0870836-A1 | 2-Deoxyglucose-6-Phosphate (2-DOG-6-P) Phosphatase DNA sequences for use as selectionmarker in plants | IPK Gatersleben (DE) | 1998-10-14 | — | — | EP | claimed |
| EP-0508346-B1 | Process for the enzymatic synthesis of 2-desoxy-bêta-D-galactosides | HOECHST AG (DE) | 1996-07-17 | — | — | EP | claimed |
| US-5264352-A | The enzyme galactosyl transferase catalyze the transfer of 2-deoxygalactose residue from uridine-5-diphospho-2-deoxy-D-galactose to N-acetyl-glucosamien or aspartyl-N-acetyl glucosamine | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-11-23 | — | — | US | claimed |
| EP-0508346-A2 | Process for the enzymatic synthesis of 2-desoxy-bêta-D-galactosides | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220023207-A1 | DRUG DELIVERY SYSTEM USING SOLUTION | PDIA6, PDIA5, DUS2 | MPI 931/4885PGD 1334/4885PGK1 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.